News Breaks |
|
|
| November 4, 2012 |
| 14:26 EDT |  | BMY, GSK, SNY, MRK, NVS, LLY, RHHBY, PFE, JNJ, AZN | In new hit for 'big pharma' India revokes patent on Roche drug, Reuters says
India's Intellectual Property Appellate Board, IPAB, revoked a patent granted six years ago on Roche's (RHHBY) hepatitis C drug Pegasys, says Reuters.Reference Link |
|
|
News For RHHBY;AZN;PFE;LLY;JNJ;SNY;BMY;MRK;GSK;NVS From The Last 14 Days Check below for free stories on RHHBY;AZN;PFE;LLY;JNJ;SNY;BMY;MRK;GSK;NVS the last two weeks. |
|
|
| June 19, 2013 |
| 16:01 EDT |  | PFE | Options Update; June 19, 2013
 Subscribe for More Information |
|
| 15:17 EDT |  | LLY | Eli Lilly issues alert for illegal scams
Eli Lilly and Company issued an alert about two illegal scams, purportedly using the name of the company and/or its subsidiary Elanco Animal Health, that are actively targeting the public through postal mail solicitations and job-seekers through online dialogue. Lilly and Elanco have no connection to any foreign lottery organizations and do not conduct the type of online recruiting described by the job-seeking victims of the scam. The activities described in these scams are completely fraudulent and are in no way affiliated with, or sponsored by, Eli Lilly and Company or its affiliates or subsidiaries. |
|
| 13:53 EDT |  | SNY | Sanofi to hold a conference call
Subscribe for More Information |
|
| 13:50 EDT | | JNJ | J&J issued FDA warning letter on Xarelto advertising
Subscribe for More Information |
|
| 10:46 EDT | | RHHBY | Alexion mentioned as possible target for Roche in London Times
Reference Link |
|
| 10:30 EDT | | PFE | Pfizer management to meet with ISI Group
Subscribe for More Information |
|
| 09:38 EDT | | MRK | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL AMAT FDX MA C GOOG DISH AMRN MRK BIDU |
|
| 08:45 EDT | | RHHBY, JNJ | Leerink's biotech analyst holds analyst/industry conference call on ADA
Analyst Antlaffy, along with Dr. George Grunberger, founder & Chairman of the Grunberger Diabetes Institute, preview the upcoming American Diabetes Association's conference, including perspectives on new devices in diabetes, potential disruptive technologies at ADA and progress towards the artificial pancreas on an Analyst/Industry conference call to be held on June 20 at 2 pm. |
|
| 07:41 EDT |  | PFE | Pfizer holders should consider Zoetis exchange, says BMO Capital
BMO Capital thinks Pfizer (PFE) investors should consider participating in the Zoetis (ZTS) exchange as they have the opportunity to own Zoetis at around $29.40-$29.70 per share, which is 15% below BMO's valuation of $34 per share. Further, BMO thinks there is strong support for Zoetis below $30, which the firm feels lowers downside risk. BMO recommends that Pfizer investors tender around 20% of their shares into the exchange, noting that with the offer likely being oversubscribed, not all tendered shares will be converted to Zoetis. |
|
| 05:43 EDT | | BMY, AZN | AstraZeneca, Bristol-Myers announce top line results of Phase 4 trial of Onglyza
Subscribe for More Information |
| |
| June 18, 2013 |
| 16:00 EDT | | MRK | Options Update; June 18, 2013
Subscribe for More Information |
|
| 12:32 EDT | | AZN | AstraZeneca CEO says turnaround to take three or four years, Reuters reports
It will likely take three or four years for AstraZeneca's turnaround efforts to bear fruit, the company's CEO, Pascal Soriot, said today, according to Reuters. Reference Link |
|
| 10:17 EDT | | LLY | Lilly puts active on FDA says investigating two deaths after Zyprexa injections
Subscribe for More Information |
|
| 10:12 EDT | | LLY | FDA investigating two deaths of patients taking Lilly's Zyprexa
The FDA said in a safety announcement on its website that it is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa. The patients died 3-4 days after receiving an appropriate dose of the drug, well after the 3-hour post-injection monitoring period required under the Zyprexa Risk Evaluation and Mitigation Strategy, the agency said. Both patients were found to have very high olanzapine blood levels after death. Eli Lilly is the maker of Zyprexa. |
|
| 09:38 EDT | | PFE | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM |
|
| 08:38 EDT | | SNY | Sanofi management to meet with JPMorgan
Subscribe for More Information |
|
| 08:37 EDT | | MRK, GSK, AZN | Drug companies turn to microchips to test medicines, WSJ reports
Subscribe for More Information |
|
| 07:34 EDT | | JNJ | Medivation pullback a buying opportunity, says JPMorgan
Subscribe for More Information |
|
| 07:22 EDT | | AZN, NVS | Citigroup to host a conference
Subscribe for More Information |
|
| 07:13 EDT | | GSK | Aspen in talks buy GSK's Arixtra, Fraxiparine brands
Subscribe for More Information |
| |
|
|
|
|
